Skip to content
Search

Latest Stories

Continuing expansion, Well Pharmacy acquires Bridge Pharmacy

Continuing its expansion, the UK’s largest independent pharmacy chain Well Pharmacy has acquired Bridge Pharmacy on Bridge Street in Newcastle Emlyn, Carmarthenshire.

This follows recent acquisition of Treharris Pharmacy in South Wales.


Louis Purchase 2 Louis Purchase, operations director of Well Pharmacy

Lauding the care and service offered by Bridge Pharmacy to the local community of Newcastle Emlyn Louis Purchase, operations director of Well Pharmacy said: “We share the same mission – we are here for the wellbeing of our patients and customers, providing access to vital healthcare advice, services and medication.

“Our vision is to provide the best community pharmacy experience in the UK and by bringing the expertise of Bridge Pharmacy team into our business we are now one step closer to achieving that goal. We hope our new colleagues will continue to progress and grow their clinical skills and careers even further by being part of Well Pharmacy.”

Sam Ghafar, regional operations manager for South, West and North Wales of Well Pharmacy, said: “We will be retaining the brilliant and skilled pharmacy colleagues so we can continue to deliver the same outstanding patient care the local community have come to expect.

“By joining Well, the pharmacy team will benefit from moving to the most advanced dispensing model for bricks and mortar pharmacies in the UK, which means the pharmacist and team will be freed up to spend more time to care for patients driving better health outcomes for the local community.”

Further, Well will rebrand Bridge Pharmacy and prioritise onboarding the new pharmacy team into the Well business.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less